SPORE/JCCC GU Oncology Leader in the Field seminar series
Dean Tang, PhD
Department of Epigenetics & Molecular Carcinogenesis, MD Anderson Cancer Center, University of Texas
Prostate cancer cell heterogeneity and clinical implications.
Tuesday, December 02, 2014; 12 to 1 p.m.; at the 63-105 CHS seminar room
Edie and Lew Wasserman Building, new home of the Urologic Oncology Institute, opens
Dr. Lili Yang, SPORE Career Development Program Awardee, receives NIH Innovator Award
Dr. Lili Yang, assistant professor of microbiology, immunology and molecular genetics at UCLA, receives the prestigious National Institutes of Health (NIH) Director’s New Innovator Award.
Prostate Cancer Research Symposium, 8:30 am – 12:30 pm
Auditorium of the California NanoSystems Institute, UCLA
The Symposium is free and open to the public. Registration is required at the Symposium Website.
The UCLA Specialized Program of Research Excellence (SPORE) in Prostate Cancer hosts a public research symposium at the UCLA Auditorium of the California NanoSystems Institute (CNSI) Auditorium on Monday, September 08, 2014, from 8:30 am to 12:30 pm. The symposium focuses on the most pressing and challenging issues in prostate cancer research, addressing topics that range from the molecular mechanisms that underlie the disease to various translational approaches.
Dr. Robert Reiter receives CIRM Early Translational grant.
Dr. Robert Reiter, Bing Professor of Urologic Research, Director of UCLA’s Prostate Cancer Program, and the PI of the UCLA SPORE of Prostate Cancer, has been awarded an Early Translational Grant from the California Institute for Regenerative Medicine (CIRM).
Dr. Owen Witte inducted into the American Association for Cancer Research Academy
Dr. Owen Witte, director of UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, professor of microbiology, immunology and molecular genetics department, and the Co-PI of the UCLA SPORE in Prostate Cancer, has been inducted into the American Association for Cancer Research (AACR) Academy.
Scientists take fight against prostate cancer from lab to clinic
The UCLA Newsroom features an article on the SPORE in Prostate Cancer and the recent renewal of NCI funding for a five-year cycle.
The UCLA SPORE in Prostate Cancer receives $11.6 M NCI grant renewal
UCLA's Jonsson Comprehensive Cancer Center and the department of urology at the David Geffen School of Medicine at UCLA have been notified that their standing as a National Cancer Institute Specialized Program of Research Excellence (SPORE) site in prostate cancer has been renewed for another five years.